Senior Director And Head, Computational Pathology Strategic Partnerships
Current
Oct 2024 - Present
AeroLeads people directory · profile
Mark Gustavson Email & Phone Number
Computational Pathology | Digital Pathology | Companion Diagnostics | Regulatory | Oncology Drug Development | Translational Medicine
at
AstraZeneca
1 work email found
@astrazeneca.com
3 phones found area 203
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Computational Pathology | Digital Pathology | Companion Diagnostics | Regulatory | Oncology Drug Development | Translational Medicine
Location
Gaithersburg, Maryland, United States
Who is Mark Gustavson? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Mark Gustavson is listed as Computational Pathology | Digital Pathology | Companion Diagnostics | Regulatory | Oncology Drug Development | Translational Medicine at AstraZeneca, based in Gaithersburg, Maryland, United States. AeroLeads shows a work email signal at astrazeneca.com, phone signal with area code 203, and a matched LinkedIn profile for Mark Gustavson.
Mark Gustavson previously worked as Senior Director and Head, Computational Pathology Strategic Partnerships at Astrazeneca and Senior Director and Head, Computational Pathology Translational Science at Astrazeneca. Mark Gustavson holds Doctor Of Philosophy (Phd), Oncology And Cancer Biology/Molecular Biology from Vanderbilt University School Of Medicine.
Company email context
Email format at AstraZeneca
This section adds company-level context without repeating Mark Gustavson's masked contact details.
{first}.{last}@astrazeneca.com
86% confidence
AeroLeads found 1 current-domain work email signal for Mark Gustavson. Compare company email patterns before reaching out.
Profile bio
About Mark Gustavson
Dedicated and accomplished biotechnology professional with 20+ years of experience in translational and clinical oncology research & development including strategic biomarker and diagnostic development in drug development, both early and late phase oncology. One plus years direct regulatory experience at the Food and Drug Administration (FDA) including leading reviews for companion diagnostic products as well as developing regulatory guidance and policy. Additionally, have 10+ years of experience in scientific group management and laboratory operations. Expertise in digital and computational pathology, image analysis through AI and deep learning, immunohistochemistry, quantitative immunofluorescence and assay development with experience in advanced statistical analysis; advanced molecular diagnostic technologies including next-generation sequencing (NGS), quantitative PCR, and circulating tumor cell and DNA technologies.Specialties: Biomarker diagnostic research clinical development; CLIA laboratory development and operations; assay development; biomarker translational and clinical research; diagnostic assay and platform development; digital pathology and image analysis (deep learning and AI); immunohistochemistry; fluorescence; molecular methods including qPCR, FISH/ISH and next-generation sequencing (NGS); analytical methods development; advanced statistical analysis; cellular and molecular biology; FDA submissions. Medical Science Liaison as well as sales training and support.
Listed skills include Assay Development, Immunohistochemistry, Biotechnology, Biomarkers, and 21 others.
Current workplace
Mark Gustavson's current company
Company context helps verify the profile and gives searchers a useful next step.
14 roles · 29 years
Mark Gustavson work experience
A career timeline built from the work history available for this profile.
Senior Director And Head, Computational Pathology Translational Science
Jun 2023 - Oct 2024
Senior Director, Translational Medicine, Oncology R&D
Jul 2021 - Jul 2023
Director, Translational Medicine, Oncology R&D
Aug 2019 - Jul 2021
Director, Precision Medicine, Oncology R&D
Sep 2017 - Aug 2019
Senior Staff Fellow
Fda - Division Of Molecular Genetics And Pathology
May 2016 - Aug 2017
Vice President, Diagnostics
Developed cutting edge diagnostic tests based on Digital Pathology-AI to affect the better treatment of cancer patients. Managing a team of scientists, we built a state-of-the-art CLIA laboratory from the ground up to enable the development and analytical validation, under CLIA regulations, of two cancer diagnostic LDT tests. Additionally, we integrated.
Aug 2014 - Mar 2016
Biotechnology Consultant
Self-Employed Biotechnology Consultant
Biotechnology consulting services including strategic biomarker research and development, diagnostics product development, biomarker clinical trials, assay development, digital pathology, image analysis, medical writing, advanced statistical analysis, applications support, medical science liaison, as well as sales, sales support and sales training.
Oct 2013 - Aug 2014
Consultant
Driving clinical adoption of next-generation clinical biomarker diagnostic assays through identification, procurement, and/or design of biomarker clinical trials to validate biomarker diagnostic assays. Identifying promising new biomarker(s) assays in consideration for clinical development through direct collaboration with Key Opinion Leaders (KOLs)..
Apr 2013 - Jul 2014
Director, Development And Operations
Historx, Inc.
Company's lead scientist with overall responsiblity for scientific initiatives related to biomarker and diagnostic assay and platform development. Managed the Pharma Services group ultimately leading to companion diagnostic development through biomarker translational and clinical research including biomarker clinical trial design, implementation, and.
May 2011 - Apr 2013
Assistant Director, Operations
Historx, Inc.
Direct day-to-day laboratory and analytical operations for our Pharma Services Division providing biomarker disovery, translational medicine, and companion diagnostic develoment services. Maintain current and establish new customer relationships. Also, lead development of analytical and statistical methods related to company's proprietary technology (AQUA.
Aug 2010 - May 2011
Sr. Research Scientist
Historx, Inc.
Nov 2006 - Mar 2010
Post-Doctoral Fellow
2005 - 2006
~1 yr
Graduate Student
1997 - 2004
~7 yrs
1 education record
Mark Gustavson education
-
Vanderbilt University School Of Medicine
FAQ
Frequently asked questions about Mark Gustavson
Quick answers generated from the profile data available on this page.
What company does Mark Gustavson work for?
Mark Gustavson works for AstraZeneca.
What is Mark Gustavson's role at AstraZeneca?
Mark Gustavson is listed as Computational Pathology | Digital Pathology | Companion Diagnostics | Regulatory | Oncology Drug Development | Translational Medicine at AstraZeneca.
What is Mark Gustavson's email address?
AeroLeads has found 1 work email signal at @astrazeneca.com for Mark Gustavson at AstraZeneca.
What is Mark Gustavson's phone number?
AeroLeads has found 3 phone signal(s) with area code 203 for Mark Gustavson at AstraZeneca.
Where is Mark Gustavson based?
Mark Gustavson is based in Gaithersburg, Maryland, United States while working with AstraZeneca.
What companies has Mark Gustavson worked for?
Mark Gustavson has worked for Astrazeneca, Fda - Division Of Molecular Genetics And Pathology, Metastat, Inc., Self-Employed Biotechnology Consultant, and Genoptix.
How can I contact Mark Gustavson?
You can use AeroLeads to view verified contact signals for Mark Gustavson at AstraZeneca, including work email, phone, and LinkedIn data when available.
What schools did Mark Gustavson attend?
Mark Gustavson holds Doctor Of Philosophy (Phd), Oncology And Cancer Biology/Molecular Biology from Vanderbilt University School Of Medicine.
What skills is Mark Gustavson known for?
Mark Gustavson is listed with skills including Assay Development, Immunohistochemistry, Biotechnology, Biomarkers, Fluorescence Microscopy, Oncology, Glp, and Lifesciences.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial